Suchergebnisse - Hong Zuo
- Treffer 1 - 3 von 3
-
1
Sodium-glucose cotransporter-1 inhibition and depression: A Mendelian randomization study von Gang Fan, Hong Zuo, Xun Shi, Bo Liu
Veröffentlicht 2025-07-01Objective: The present study aims to determine the causal association between sodium-glucose cotransporter inhibitors and depression, as previous observational studies have concluded a potential link between sodium-glucose cotransporter 1/2 inhibition and depression. Methods: A total of 16 instrumen...
Volltext
Artikel -
2
The Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors for Patients with Anticancer Therapy: A Meta-Analysis of Cohort Studies von Gang Fan, Hong Zuo, Lin Lin, Chao Xu, Rui Yan
Veröffentlicht 2025-06-01Background: Chemotherapy-induced cardiotoxicity is the leading cause of non-tumorrelated mortality among patients with tumors. Although sodium glucose cotransporter 2 inhibitors (SGLT2is) have been shown to confer cardiovascular benefits, their effects and safety profile in patients with cancer rema...
Volltext
Artikel -
3
A case report of ‘Two-Hit’ digenic mutations in PAH: role of PADN in management von Zai-qiang Zhang, Zai-qiang Zhang, Zhou-qiang Qin, Zhou-qiang Qin, Sheng-kui Zhu, Sheng-kui Zhu, Yu-hong Zuo, Yu-hong Zuo, Jia-wang Ding, Jia-wang Ding
Veröffentlicht 2025-07-01BackgroundPulmonary arterial hypertension (PAH) is a severe cardiopulmonary disorder characterized by progressive elevation of pulmonary vascular resistance, resulting to right ventricular dysfunction and premature mortality. Although genetic mutations are increasingly recognized in PAH pathogenesis...
Volltext
Artikel